Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: Insights from the RESOLUTE All Comers Trial

Heart

Volumn 99, Issue 17, 2013, Pages 1267-1274

  Diletti, Roberto ^a   Garcia Garcia, Hector M ^b   Bourantas, Christos V ^a   Van Geuns, Robert Jan ^a   Van Mieghem, Nicolas M ^a   Vranckx, Pascal ^c   Zhang, Yao Jun ^a   Farooq, Vasim ^a   Iqbal, Javaid ^a   Wykrzykowska, Joanna J ^d   De Vries, Ton ^b   Swart, Michael ^b   Teunissen, Yvonne ^b   Negoita, Manuela ^e   Van Leeuwen, Frank ^e   Silber, Sigmund ^f   Windecker, Stephan ^g   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c VIRGA JESSE HOSPITAL   (Belgium)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MEDTRONIC INC   (United States)

^f Heart Centre at Isar   (Germany)

^g BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; ZOTAROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BIFURCATION LESION; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT THROMBOSIS;

AGED; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 84881481700     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303778     Document Type: Article

References (45)

1. George BS, Myler RK, Stertzer SH, et al. Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Catheter Cardiovasc Diagn 1986;12:124-38. (Pubitemid 16116949)
2. Pinkerton CA, Slack JD, Van Tassel JW, et al. Angioplasty for dilatation of complex coronary artery bifurcation stenoses. Am J Cardiol 1985;55:1626-8. (Pubitemid 15059299)
3. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent-immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-51. (Pubitemid 30206888)
4. Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-83. (Pubitemid 30133517)
5. Sheiban I, Albiero R, Marsico F, et al. Immediate and long-term results of 'T' stenting for bifurcation coronary lesions. Am J Cardiol 2000;85:1141-4, A9. (Pubitemid 30214265)
6. Karvouni E, Di Mario C, Nishida T, et al. Directional atherectomy prior to stenting in bifurcation lesions: a matched comparison study with stenting alone. Catheter Cardiovasc Interv 2001;53:12-20. (Pubitemid 32405740)
7. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol 2000;35:929-36. (Pubitemid 30189924)
8. Thuesen L, Kelbaek H, Klovgaard L, et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). Am Heart J 2006;152:1140-5. (Pubitemid 44872987)
9. Colombo A, Al-Lamee R. Bifurcation lesions: an inside view. Circ Cardiovasc Interv 2010;3:94-6.
10. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109:1244-9. (Pubitemid 38372783)
11. Tanabe K, Hoye A, Lemos PA, et al. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 2004;94:115-18. (Pubitemid 38813465)
12. Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-64.
13. Sheiban I, Villata G, Bollati M, et al. Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V). Vasc Health Risk Manag 2008;4:31-8. (Pubitemid 351467378)
14. Doostzadeh J, Clark LN, Bezenek S, et al. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Coron Artery Dis 2010;21:46-56.
15. Lopez JJ, Keyes MJ, Nathan S, et al. Rapid adoption of drug-eluting stents: clinical practices and outcomes from the early drug-eluting stent era. Am Heart J 2010;160:767-74.
16. Serruys PW, Silber S, Garg S, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010;363:136-46.
17. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:1663-74.
18. Lange RA, Hillis LD. Second-generation drug-eluting coronary stents. N Engl J Med 2010;362:1728-30.
19. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
20. Vranckx P, Cutlip DE, Mehran R, et al. Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. Euro Interv 2010;5:871-4.
21. Reiber JH, Serruys PW. Quantitative coronary angiography: methodologies. Quantitative coronary angiography. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1991:98-102.
22. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
23. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. (Pubitemid 38067635)
24. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007;356:1030-9. (Pubitemid 46376803)
25. Virmani R, Guagliumi G, Farb A, et al
26. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 2007;115:1440-55; discussion 55. (Pubitemid 46648381)
27. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-78. (Pubitemid 46281313)
28. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006;48:2584-91. (Pubitemid 44881238)
29. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
30. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
31. Farb A, Boam AB. Stent thrombosis redux-the FDA perspective. N Engl J Med 2007;356:984-7. (Pubitemid 46376798)
32. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333-42. (Pubitemid 352001347)
33. Virmani R, Farb A, Guagliumi G, et al. Drug-eluting stents: caution and concerns for long-term outcome. Coron Artery Dis 2004;15:313-18. (Pubitemid 39299245)
34. Mukherjee D, Moliterno DJ. Second-generation drug-eluting stents and the continuous need for rapidly available real-world data. JACC Cardiovasc Interv 2009;2:1236-9.
35. Basalus MW, van Houwelingen KG, Ankone MJ, et al. Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. Euro Interv 2010;6:141-8.
36. Garg S, Wykrzykowska J, Serruys PW, et al. The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. Euro Interv 2011;6:928-35.
37. von Birgelen C, Basalus MW, Tandjung K, et al. A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial. J Am Coll Cardiol 2012;59:1350-61.
38. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008;299:1903-13. (Pubitemid 351574920)
39. Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Circulation 2009;119:680-6.
40. Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6. (Pubitemid 37243657)
41. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. (Pubitemid 40617065)
42. Colombo A, Bramucci E, Sacca S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation 2009;119:71-8.
43. Louvard Y, Thomas M, Dzavik V, et al
44. Hildick-Smith D, de Belder AJ, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation 2010;121:1235-43.
45. Niemela M, Kervinen K, Erglis A, et al. Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III. Circulation 2011;123:79-86.